Poland· PL-100480270
Benoxam
A benfotiamine product containing benfothiaminum, registered in Poland by Solinea Sp. z o.o.. The same ATC class is registered in 4 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Benfotiamine is registered in 4 of 19 countries.
Countries holding a registration under ATC A11DA03 (benfotiamine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 3 of them publish a price we can compare per daily dose
Benfotiamine · ATC A11DA03
4 / 19 countries
- Czechiaprice
- Germany
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Benfothiaminum
- Manufacturer
- Solinea Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- A11DA03
- ATC class
- Benfotiamine
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05907572581157
- gtin05907572581164
- gtin05907572581171
- gtin05907572581188
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Benfotiamine in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBENFOGAMMAWörwag Pharma GmbH & Co. KG, Böblingen
- GermanyBenfoWörwag Pharma Gmbh & Co. Kg
- SpainMELGAMA 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULAAaa-Pharma Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Milgamma Protect
- Bulgaria · Бенфогамма, Benfogamma, Милгамма Протект, Milgamma Protect
- Czechia · Benfogamma
- Germany · Benfo, Benfotiamin Gl Pharma
- Estonia · Benfogamma, Tiavella
- Spain · Melgama
- Hungary · Benfogamma, Tiavella
- Lithuania · Benfogamma, Tiavella
- Latvia · Benfogamma, Tiavella
- Portugal · Benfotiamina Tecnimede, Vilotram
- Romania · Benfogamma, Benfotiamin? G.L. Pharma
- Slovenia · Benfotiamin
- Slovakia · Benfogamma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ceb50eed-32c9-4e66-9bd2-17fcc8d42cf5 GET /v1/drugs/ceb50eed-32c9-4e66-9bd2-17fcc8d42cf5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "300 mg",
"packaging": "05907572581157 ¦ Rp ¦ 163764\n10 tabl.\n05907572581164 ¦ Rp ¦ 163765\n20 tabl.\n05907572581171 ¦ Rp ¦ 163766\n30 tabl.\n05907572581188 ¦ Rp ¦ 163767\n50 tabl.",
"substance": "Benfothiaminum 300 mg",
"common_name": "Benfothiaminum",
"pl_product_id": "100480270",
"pozwolenie_nr": "29543",
"auth_procedure": "NAR",
"authorisation_validity": "2031-02-27"
}See everything about benfotiamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.